Ozempic and Wegovy, made by Novo, are on track to become the world’s top-selling drugs by 2025. Yet in 2024, ‘Wegovy Wednesday’ had already become one of the biggest weight-loss trends to sweep the ...

Wegovy is FDA-approved for weight loss whereas Ozempic is approved for blood sugar control,” Ngo said. “The reason for differences in approvals ultimately comes down to the clinical trials ...

According to GoodRx, compliance rates are high, with only 9% of commercially insured people having full Zepbound coverage and 14% having full Wegovy coverage. This refers to insurance coverage that ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year ...

Wegovy also has been approved as a treatment to reduce the risk of heart attack and stroke. Consumer advocates and elected officials have raised concerns about the prices of GLP-1 medications ...

Eli Lilly (LLY -1.28%) and Novo Nordisk (NVO 1.03%) have competed for decades. They're both leaders in the areas of insulin ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of ...

Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO -1.51%) stock ...

The Maryland program’s spending on both obesity drugs grew 86% year-over-year, Real Chemistry said, the seventh highest in ...

Share on Pinterest Wegovy is a glucagon-like peptide-1 (GLP-1) medication with Food and Drug Administration (FDA) approval for weight loss. The drug is the brand-name version of the medication ...